StockSelector.com
  Research, Select, & Monitor Thursday, July 19, 2018 7:25:26 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
   Diversify with StockSelector.com
- the tools for short-term traders and long-term investors to find successful ideas to fit their strategies and to keep informed of the stocks you follow or hold. Take a macro look at the market and by industry, narrow down to specific stocks and the right time, then use our portfolio to monitor the stocks and be alerted of changes.


 Sector ETF's Price Change  
S&P 500 Cons Disc Sector SPDR 112.65 (0.23%)
S&P 500 Cons Staples Sector SPDR 52.54 0.06%
S&P 500 Energy Sector SPDR 75.15 0.03%
S&P 500 Financials Sector SPDR 27.51 (1.50%)
S&P 500 Healthcare Sector SPDR 86.93 (0.56%)
S&P 500 Industrial Sector SPDR 74.52 (0.04%)
S&P 500 Materials Sector SPDR 58.53 0.36%
S&P 500 Info Tech Sector SPDR 72.53 (0.36%)
S&P 500 Utilities Sector SPDR 52.66 0.92%

 Most Oversold Industry
 Auto Manufacturers - Major
These firms are some of the largest vehicle manufacturers in the world. They produce the obvious cars, trucks, buses, vans, and motorcycles. Recreational vehicles, mini-vans, luxury cars, components, and construction equipment are some of their other related items on the production lines. Many firms also offer financing of their goods and in a field tied to vehicle financing, one firm here offers mortgages and even auto and homeowner's insurance. They typically sell their product to the consumer through auto dealerships located domestically and abroad.


Citigroup Beats by a Penny
7/13/2018 7:59:00 AM


1.23%
Citigroup, Inc. (C) reported second quarter earnings of $1.63 per share on revenue of $18.47 billion. The consensus earnings estimate was $1.54 per share on revenue of $18.58 billion for the quarter ending June 30, 2018. The Earnings ... more

Casey's Misses More Than Expected
6/12/2018 8:41:00 AM



0.48%
Casey's General Stores, Inc. (CASY) reported fourth quarter earnings of $0.51 per share on revenue of $2.09 billion. The consensus earnings estimate was $0.68 per share on revenue of $2.14 billion for the quarter ending April 30, 2018. ... more

Palo Alto Networks Beats Consensus but Misses Whisper
6/4/2018 7:30:00 AM


0.76%
Palo Alto Networks, Inc. (PANW) reported third quarter earnings of $0.99 per share on revenue of $567.1 million. The consensus earnings estimate was $0.96 per share on revenue of $545.8 million for the quarter ending April 30, 2018. ... more

Michael Kors Beats Consensus but Misses Whisper
5/30/2018 6:55:00 AM



1.31%
Michael Kors Holdings Limited (KORS) reported fourth quarter earnings of $0.63 per share on revenue of $1.18 billion. The consensus earnings estimate was $0.60 per share on revenue of $1.14 billion for the quarter ending March 31, 2018. ... more

Best Buy Beats
5/24/2018 7:00:00 AM



2.13%
Best Buy Co., Inc. (BBY) reported first quarter earnings of $0.82 per share on revenue of $9.11 billion. The consensus earnings estimate was $0.75 per share on revenue of $8.76 billion for the quarter ending April 30, 2018. The Earnings ... more

Ralph Lauren Reports In-line
5/23/2018 8:01:00 AM



1.18%
Ralph Lauren Corporation (RL) reported fourth quarter earnings of $0.90 per share on revenue of $1.53 billion. The consensus earnings estimate was $0.85 per share on revenue of $1.49 billion for the quarter ending March 31, 2018. The ... more

 StockSelector's Top Ranked Stock
 Axcelis Technologies, Inc.
Positive Points:20
Negative Points:1
Axcelis Technologies is a leading producer of ion implantation equipment used in the fabrication of semiconductors. The company also produces dry strip, photostabilization and rapid thermal processing equipment, which is used in semiconductor manufacturing primarily before and after the ion implantation process. In addition, the company provides extensive aftermarket service and support, including spare parts, equipment upgrades, maintenance services and customer training.

 Potential Breakout Stock
 Pain Therapeutics, Inc.
Pain Therapeutics is developing a new generation of opioid painkillers. Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs, such as morphine, into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical trials. The company believes its drugs offer enhanced pain relief, fewer adverse side effects and reduced tolerance and addiction compared to existing opioid painkillers.











Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Quotes are delayed by 15-20 minutes. Quotes provided by QuoteMedia

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.